StockScan › Stocks › XXII
Biotechnology
XXII
4.02
  Price0.50%   +0.0200
(After Hours: 4.02 0 +0.00%)
KEY STATS
Previous Close:
$4.00
Market Cap:
$612.64M
24h Volume:
$6.37M
1D Range:
$3.94 - $4.25
52W Range:
$0.55 - $4.66
Primary Exchange:
COMPANY PROFILE
NameName22nd Century Group
SectorHealthcare (1071)
IndustryBiotechnology (641)
Webxxiicentury.com
Phone716-270-1523
Employee79
Twitter @_xxiicentury
Latest SEC Filings
8560 Main Street, Williamsville, NY, United States (14221)
News Options Financials Holders Transactions Discussions Predictions
Apr-22-21 10:35AM 22nd Century Group to Host Webcast to Discuss First Quarter 2021 ResultsGlobeNewswire
Apr-21-21 10:35AM 22nd Century Group Issues Annual Letter to ShareholdersGlobeNewswire
Apr-20-21 04:00AM 22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.GlobeNewswire
Apr-15-21 05:56AM 22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action PlanGlobeNewswire
Apr-08-21 10:06AM 22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products CommitteeGlobeNewswire
Apr-06-21 07:12AM 3 Best Emerging Marijuana Stocks to Buy in AprilMotley Fool
Apr-01-21 10:06AM Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd CenturyGlobeNewswire
Mar-23-21 09:30AM 22nd Century Group (NYSEMKT:XXII) Is In A Good Position To Deliver On Growth PlansSimply Wall St.
Mar-19-21 01:00AM Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco IndustryGlobeNewswire
08:30AM Do Options Traders Know Something About 22nd Century (XXII) Stock We Don't?Zacks
Mar-12-21 01:55AM Why 22nd Century Group Stock Just Lit UpMotley Fool
10:00AM 22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding WarrantsGlobeNewswire
Mar-11-21 06:30AM 22nd Century Group (XXII) Q4 2020 Earnings Call TranscriptMotley Fool
07:00AM 22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020GlobeNewswire
Mar-05-21 09:15AM 22nd Century Group to Participate in Investor Conferences in March 2021GlobeNewswire
Mar-04-21 12:30PM Will 22nd Century Group (XXII) Report Negative Earnings Next Week? What You Should KnowZacks
09:15AM 22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding WarrantsGlobeNewswire
Mar-03-21 09:00AM 22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual PropertyGlobeNewswire
Feb-25-21 07:30AM 22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 ResultsGlobeNewswire
Feb-24-21 10:00AM 22nd Century Group Provides Business Update Letter from CEOGlobeNewswire
Feb-10-21 10:00AM 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable TraitsGlobeNewswire
Jan-28-21 10:00AM 22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville DistrictGlobeNewswire
Jan-26-21 12:00PM The Buffalo News Op-ed: 22nd Century CEO Urges FDA to Proceed with Plan to Limit Nicotine Levels in CigarettesGlobeNewswire
Jan-19-21 07:30AM Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century GroupGlobeNewswire
Jan-12-21 11:00AM 22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content CigarettesGlobeNewswire
Jan-11-21 12:00PM 22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content CigarettesGlobeNewswire
Dec-23-20 04:49AM Did Business Growth Power 22nd Century Group's (NYSEMKT:XXII) Share Price Gain of 116%?Simply Wall St.
Dec-17-20 10:10AM 22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable CannabinoidsGlobeNewswire
Dec-15-20 08:54AM Is the Options Market Predicting a Spike in 22nd Century (XXII) Stock?Zacks
Dec-14-20 08:49AM Is the Options Market Predicting a Spike in 22nd Century (XXII) Stock?Zacks
Dec-08-20 10:00AM 22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported ResearchGlobeNewswire
Dec-04-20 10:00AM 22nd Century Group to Present at 13th Annual LD Micro Main Event ConferenceGlobeNewswire
Nov-29-20 08:37AM Is 22nd Century Group, Inc (XXII) A Good Stock To Buy?Insider Monkey
Nov-24-20 11:00AM 22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy ArticleGlobeNewswire
Nov-18-20 10:00AM 22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis ConferenceGlobeNewswire
Nov-16-20 09:45AM 22nd Century Group to Present at the Virtual Fall Investor Summit on November 17GlobeNewswire
Nov-12-20 08:36AM Implied Volatility Surging for 22nd Century (XXII) Stock OptionsZacks
Nov-05-20 10:05AM 22nd Century Group (XXII) Reports Q3 Loss, Tops Revenue EstimatesZacks
07:00AM 22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020GlobeNewswire
Oct-29-20 12:35PM 22nd Century Group (XXII) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks
Oct-22-20 10:00AM 22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&AGlobeNewswire
Oct-19-20 10:00AM 22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy ConferenceGlobeNewswire
Oct-15-20 08:58AM 22nd Century (XXII) in Focus: Stock Moves 9.9% HigherZacks
Oct-14-20 01:00AM 22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco PlantsGlobeNewswire
Sep-24-20 04:05AM 22nd Century Group Provides Strategy Update Letter from CEOGlobeNewswire
Sep-23-20 12:26PM Health Check: How Prudently Does 22nd Century Group (NYSEMKT:XXII) Use Debt?Simply Wall St.
Sep-17-20 04:05AM 22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of DirectorsGlobeNewswire
Aug-31-20 06:05AM LD Micro: 360 Companies Set to Present this WeekACCESSWIRE
Aug-27-20 11:30AM 22nd Century Group to Present at the LD Micro 500 Virtual ConferenceGlobeNewswire
Aug-06-20 07:00AM 22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020GlobeNewswire
About 22nd Century Group
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
List of Zack Morris Stocks List of SPAC Stocks List of EV Stocks and Related Stocks Top 100 popular stocks on Robinhood List of Marijuana Stocks
Open in Yahoo | Open in Google | Open in Finviz
Cap:    |  Volume (24h):